The Biosurgery Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The biosurgery market has shown robust growth over the past few years. It is projected to increase from a market size of $15.27 billion in 2024 to $16.49 billion in 2025, with a compound annual growth rate (CAGR) of 8.0%. The historical growth trend in the Biosurgery market is of a significant increase.
The biosurgery market is anticipated to expand to a worth of $22.98 billion by 2029, progressing at a compound annual growth rate (CAGR) of 8.7%.
Download Your Free Sample of the 2025 Biosurgery Market Report and Uncover Key Trends Now!The key drivers in the biosurgery market are:
• Advancements in tissue engineering
• Increase in minimally invasive procedures
• Shift towards regenerative medicine and biologics
• High demand due to aging population needs
The biosurgery market covered in this report is segmented –
1) By Product: Bone-Graft Substitutes, Soft-Tissue Attachments, Hemostatic Agents, Surgical Sealants And Adhesives, Adhesion Barriers, Staple Line Reinforcement
2) By Source: Natural Or Biologics Products, Synthetic Products
3) By Application: Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Gynecological Surgery, Other Applications
4) By End-User: Hospitals, Clinics, Other End-Users
The key trends in the biosurgery market are:
• Growth in minimally invasive procedures is an emerging trend in the biosurgery market.
• The rise in cosmetic and plastic surgeries is increasingly shaping the future of the market.
• There is a heightened focus on stem cell therapies, steering the direction of the market.
• Advancements in wound care and the development of biodegradable products are important trends in the biosurgery space.
Major companies in the biosurgery market are:
• Baxter International Inc.
• B. Braun SE
• Becton, Dickinson and Company
• Hemostasis LLC
• Integra LifeSciences Corporation
• Johnson & Johnson Services Inc.
• CryoLife Inc.
• CSL Limited
• Pfizer Inc.
• Zimmer Biomet Holdings Inc.
• Kuros Biosciences AG
• Orthofix Medical Inc.
• Smiths & Nephew plc
• Medtronic plc
• Stryker Corp.
• Betatech Medical
• Tissue Regenix Group plc
• Aroa Biosurgery Ltd.
• Anika Therapeutics Inc.
• Arthrex Inc.
• B Braun Surgical SA
• Biom'Up SA
• Boston Scientific Corporation
• Coloplast Corp.
• Cook Medical Inc.
• Endo International plc
• Genzyme Corporation
• Takeda Pharmaceutical Company Limited
• Cerus Corporation
North America was the largest region in the biosurgery market in 2024